IncellDx Competitors and Similar CompaniesClear all
IncellDx's competitors and similar companies include BioFluidica, Arrayit Corporation, CHA Vaccine Institute and HelixBind.
 BioFluidica BioFluidica is a biotechnology company that develops a diagnostic platform allowing for disease management and diagnosis through prognosis. |  Arrayit Corporation Arrayit Corporation is a company engaged in the discovery, development, and manufacture of proprietary life science technologies and consumables for disease prevention, treatment, and cure. |  CHA Vaccine Institute CHA Vaccine Institute ((주)차백신연구소, formerly known as Dubeel) is a research-oriented biotechnology company. |  HelixBind HelixBind is a company that develops a diagnostic platform to detect bloodstream infections. | ||
Founding Date | Founding Date 2009 | Founding Date 2006 | Founding Date 1993 | Founding Date 2000 | Founding Date 2013 |
Type | Type Private | Type Private | Type Public | Type Public | Type Private |
Tags | |||||
Locations | Locations San Carlos, US HQ | Locations San Diego, US HQ Lawrence, US | Locations Sunnyvale, US HQ | Locations Seongnam, KR HQ | Locations Boxborough, US HQ |
Employees | Employees 224% decrease | Employees 7 | Employees 7 | Employees 477% increase | Employees 31 |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $4.4m (FY, 2014) | Revenue (est.) ₩370.7m (FY, 2024) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods $1.8m (FY, 2014) | Cost of goods ₩23.9m (FY, 2024) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit $2.6m (FY, 2014) | Gross profit ₩355.1m (FY, 2024) | Gross profit N/A |
Net income | Net income N/A | Net income N/A | Net income ($3.3m) (FY, 2014) | Net income (₩10.1b) (FY, 2024) | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round $ 6m (almost 14 years ago) | Latest funding round $ 3.1m (over 6 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 1.7m (about 12 years ago) |
Total funding raised | Total funding raised $ 9m | Total funding raised $ 9.2m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 1.7m |
For sources of this data, please see the company profile
View Company Profiles
BioFluidica
HQ
San Diego, US
Employees
7
BioFluidica is a biotechnology company that develops a diagnostic platform allowing for disease management and diagnosis through prognosis.
View companyArrayit Corporation
HQ
Sunnyvale, US
Employees
7
Arrayit Corporation is a company engaged in the discovery, development, and manufacture of proprietary life science technologies and consumables for disease prevention, treatment, and cure.
View companyCHA Vaccine Institute
HQ
Seongnam, KR
Employees
47↑ 7% increase
CHA Vaccine Institute ((주)차백신연구소, formerly known as Dubeel) is a research-oriented biotechnology company.
View companyHelixBind
HQ
Boxborough, US
Employees
31
HelixBind is a company that develops a diagnostic platform to detect bloodstream infections.
View company